What’s Next? Five Things To Look Out For In October
Reddy’s Looks To FDA NuvaRing Response; Q3 Results Hit The Market
Executive Summary
In October, Dr Reddy’s Laboratories and ANI Pharmaceuticals are among companies expecting to hear from the US Food and Drug Administration for key applications, as the annual joint conference of Medicines for Europe and the International Generic and Biosimilar medicines Association takes place in Athens, Greece.